Biochemical and kinetic properties of the complex Roco G-protein cycle

References

Aasly, J.O., Vilariño-Güell, C., Dachsel, J.C., Webber, P.J., West, A.B., Haugarvoll, K., Johansen, K.K., Toft, M., Nutt, J.G., Payami, H., et al. (2010). Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson’s disease. Mov. Disord. 25, 2156–2163.10.1002/mds.23265Search in Google Scholar PubMed PubMed Central

Ahmadian, M.R., Hoffmann, U., Goody, R.S., and Wittinghofer, A. (1997). Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry 36, 4535–4541.10.1021/bi962556ySearch in Google Scholar PubMed

Berger, Z., Smith, K.A., and Lavoie, M.J. (2010). Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 49, 5511–5523.10.1021/bi100157uSearch in Google Scholar PubMed PubMed Central

Binns, D.D., Helms, M.K., Barylko, B., Davis, C.T., Jameson, D.M., Albanesi, J.P., and Eccleston, J.F. (2000). The mechanism of GTP hydrolysis by dynamin II: a transient kinetic study. Biochemistry 39, 7188–7196.10.1021/bi000033rSearch in Google Scholar PubMed

Biosa, A., Trancikova, A., Civiero, L., Glauser, L., Bubacco, L., Greggio, E., and Moore, D.J. (2013). GTPase activity regulates kinase activity and cellular phenotypes of Parkinson’s disease-associated LRRK2. Hum. Mol. Genet. 22, 1140–1156.10.1093/hmg/dds522Search in Google Scholar PubMed

Bos, J.L., Rehmann, H., and Wittinghofer, A. (2007). GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865–877.10.1016/j.cell.2007.05.018Search in Google Scholar PubMed

Bosgraaf, L. and Van Haastert, P.J.M. (2003). Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta Mol. Cell Res. 1643, 5–10.10.1016/j.bbamcr.2003.08.008Search in Google Scholar PubMed

Chakrabarti, P.P., Suveyzdis, Y., Wittinghofer, A., and Gerwert, K. (2004). Fourier transform infrared spectroscopy on the Rap·RapGAP reaction, GTPase activation without an arginine finger. J. Biol. Chem. 279, 46226–46233.10.1074/jbc.M405603200Search in Google Scholar PubMed

Civiero, L., Vancraenenbroeck, R., Belluzzi, E., Beilina, A., Lobbestael, E., Reyniers, L., Gao, F., Micetic, I., De Maeyer, M., Bubacco, L., et al. (2012). Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS One 7, e43472.10.1371/journal.pone.0043472Search in Google Scholar PubMed PubMed Central

Deyaert, E., Wauters, L., Guaitoli, G., Konijnenberg, A., Leemans, M., Terheyden, S., Petrovic, A., Gallardo, R., Nederveen-Schippers, L.M., Athanasopoulos, P.S., et al. (2017). A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover. Nat. Commun. 8, 1008.10.1038/s41467-017-01103-4Search in Google Scholar PubMed PubMed Central

Dusonchet, J., Li, H., Guillily, M., Liu, M., Stafa, K., Derada Troletti, C., Boon, J.Y., Saha, S., Glauser, L., Mamais, A., et al. (2014). A Parkinson’s disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Hum. Mol. Genet. 23, 4887–4905.10.1093/hmg/ddu202Search in Google Scholar PubMed PubMed Central

Eberth, A. and Ahmadian, M.R. (2009). In vitro GEF and GAP assays. Curr. Protoc. Cell Biol. 43, 1–25.10.1002/0471143030.cb1409s43Search in Google Scholar PubMed

Fislage, M., Wauters, L., and Versées, W. (2016). Invited review: MnmE, a GTPase that drives a complex tRNA modification reaction. Biopolymers 105, 568–579.10.1002/bip.22813Search in Google Scholar PubMed

Gandhi, P.N., Wang, X., Zhu, X., Chen, S.G., and Wilson-Delfosse, A.L. (2008). The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J. Neurosci. Res. 86, 1711–1720.10.1002/jnr.21622Search in Google Scholar PubMed PubMed Central

Gasper, R., Meyer, S., Gotthardt, K., and Sirajuddin, M. (2009). It takes two to tango: regulation of G proteins by dimerization. Nat. Rev. Mol. Cell Biol. 10, 423–429.10.1038/nrm2689Search in Google Scholar PubMed

Gloeckner, C.J., Kinkl, N., Schumacher, A., Braun, R.J., O’Neill, E., Meitinger, T., Kolch, W., Prokisch, H., and Ueffing, M. (2006). The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15, 223–232.10.1093/hmg/ddi439Search in Google Scholar PubMed

Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P.J.M., and Wittinghofer, A. (2008). Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J. 27, 2239–2249.10.1038/emboj.2008.150Search in Google Scholar PubMed PubMed Central

Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M.P., Beilina, A., Blackinton, J., Thomas, K.J., et al. (2006). Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329–341.10.1016/j.nbd.2006.04.001Search in Google Scholar PubMed

Guaitoli, G., Raimondi, F., Gilsbach, B.K., Gómez-Llorente, Y., Deyaert, E., Renzi, F., Li, X., Schaffner, A., Jagtap, P.K.A., Boldt, K., et al. (2016). Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts. Proc. Natl. Acad. Sci. USA 113, E4357–E4366.10.1073/pnas.1523708113Search in Google Scholar PubMed PubMed Central

Guo, L., Gandhi, P.N., Wang, W., Petersen, R.B., Wilson-Delfosse, A.L., and Chen, S.G. (2007). The Parkinson’s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 313, 3658–3670.10.1016/j.yexcr.2007.07.007Search in Google Scholar PubMed PubMed Central

Haebig, K., Gloeckner, C.J., Miralles, M.G., Gillardon, F., Schulte, C., Riess, O., Ueffing, M., Biskup, S., and Bonin, M. (2010). ARHGEF7 (β-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS One 5, e13762.10.1371/journal.pone.0013762Search in Google Scholar PubMed PubMed Central

Ho, D.H., Jang, J., Joe, E., Son, I., Seo, H., and Seol, W. (2016). G2385R and I2020T mutations increase LRRK2 GTPase activity. Biomed Res. Int. 2016, 7917128.10.1155/2016/7917128Search in Google Scholar PubMed PubMed Central

Iancu, C.V., Borza, T., Fromm, H.J., and Honzatko, R.B. (2002). Feedback inhibition and product complexes of recombinant mouse muscle adenylosuccinate synthetase. J. Biol. Chem. 277, 40536–40543.10.1074/jbc.M204952200Search in Google Scholar PubMed

Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., and Iwatsubo, T. (2007). GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson’s disease. Biochemistry 46, 1380–1388.10.1021/bi061960mSearch in Google Scholar PubMed

Jaleel, M., Nichols, R.J., Deak, M., Campbell, D.G., Gillardon, F., Knebel, A., and Alessi, D.R. (2007). LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson’s disease mutants affect kinase activity. Biochem. J. 405, 307–317.10.1042/BJ20070209Search in Google Scholar PubMed PubMed Central

James, N., Digman, M., Gratton, E., and Barylko, B. (2012). Number and brightness analysis of LRRK2 oligomerization in live cells. Biophys. J. 102, L41–L43.10.1016/j.bpj.2012.04.046Search in Google Scholar PubMed PubMed Central

John, J., Sohmen, R., Feuerstein, J., Linke, R., Wittinghofer, A., and Goody, R.S. (1990). Kinetics of interaction of nucleotides with nucleotide-free H-Ras p21. Biochemistry 29, 6058–6065.10.1021/bi00477a025Search in Google Scholar PubMed

Kotting, C., Kallenbach, A., Suveyzdis, Y., Wittinghofer, A., and Gerwert, K. (2008). The GAP arginine finger movement into the catalytic site of Ras increases the activation entropy. Proc. Natl. Acad. Sci. USA 105, 6260–6265.10.1073/pnas.0712095105Search in Google Scholar PubMed PubMed Central

Liao, J., Wu, C.-X., Burlak, C., Zhang, S., Sahm, H., Wang, M., Zhang, Z.-Y., Vogel, K.W., Federici, M., Riddle, S.M., et al. (2014). Parkinson disease-associated mutation R1441H in LRRK2 prolongs the “active state” of its GTPase domain. Proc. Natl. Acad. Sci. USA 111, 4055–4060.10.1073/pnas.1323285111Search in Google Scholar PubMed PubMed Central

Liu, Z., Bryant, N., Kumaran, R., Beilina, A., Abeliovich, A., Cookson, M.R., and West, A.B. (2018). LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Hum. Mol. Genet. 27, 385–395.10.1093/hmg/ddx410Search in Google Scholar PubMed PubMed Central

Luzón-Toro, B., Rubio de la Torre, E., Delgado, A., Pérez-Tur, J., and Hilfiker, S. (2007). Mechanistic insight into the dominant mode of the Parkinson’s disease-associated G2019S LRRK2 mutation. Hum. Mol. Genet. 16, 2031–2039.10.1093/hmg/ddm151Search in Google Scholar PubMed

Meyer, S., Wittinghofer, A., and Versées, W. (2009). G-domain dimerization orchestrates the tRNA wobble modification reaction in the MnmE/GidA complex. J. Mol. Biol. 392, 910–922.10.1016/j.jmb.2009.07.004Search in Google Scholar PubMed

Milburn, M.V., Tong, L., DeVos, A.M., Brünger, A., Yamaizumi, Z., Nishimura, S., and Kim, S.H. (1990). Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science 247, 939–945.10.1126/science.2406906Search in Google Scholar PubMed

Mills, R.D., Mulhern, T.D., Liu, F., Culvenor, J.G., and Cheng, H.-C. (2014). Prediction of the repeat domain structures and impact of Parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2). Hum. Mutat. 2, 1–74.10.1002/humu.22515Search in Google Scholar PubMed

Nixon-abell, J., Berwick, D.C., and Harvey, K. (2016). L’RRK de Triomphe: a solution for LRRK2 GTPase activity? Biochem. Soc. Trans. 44, 1625–1634.10.1042/BST20160240Search in Google Scholar PubMed

Okafor, N. (2011). Environmental Microbiology of Aquatic and Waste Systems (Berlin, Germany: Springer).10.1007/978-94-007-1460-1Search in Google Scholar

Prado, S., Villarroya, M., Medina, M., and Armengod, M.-E. (2013). The tRNA-modifying function of MnmE is controlled by post-hydrolysis steps of its GTPase cycle. Nucleic Acids Res. 41, 6190–6208.10.1093/nar/gkt320Search in Google Scholar PubMed PubMed Central

Purlyte, E., Dhekne, H.S., Sarhan, A.R., Gomez, R., Lis, P., Wightman, M., Martinez, T.N., Tonelli, F., Pfeffer, S.R., and Alessi, D.R. (2018). Rab29 activation of the Parkinson’s disease-associated LRRK2 kinase. EMBO J. 37, 1–18.10.15252/embj.201798099Search in Google Scholar PubMed PubMed Central

Rudi, K., Ho, F.Y., Gilsbach, B.K., Pots, H., Wittinghofer, A., Kortholt, A., and Klare, J.P. (2015). Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations. Biosci. Rep. 35, e00254.10.1042/BSR20150128Search in Google Scholar PubMed PubMed Central

Schweins, T., Geyer, M., Scheffzek, K., Warshel, A., Kalbitzer, H.R., and Wittinghofer, A. (1995). Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21 and other GTP-binding proteins. Nat. Struct. Biol. 2, 36–44.10.1038/nsb0195-36Search in Google Scholar PubMed

Scrima, A. and Wittinghofer, A. (2006). Dimerisation-dependent GTPase reaction of MnmE: how potassium acts as GTPase-activating element. EMBO J. 25, 2940–2951.10.1038/sj.emboj.7601171Search in Google Scholar PubMed PubMed Central

Sheng, Z., Zhang, S., Bustos, D., Kleinheinz, T., Le Pichon, C.E., Dominguez, S.L., Solanoy, H.O., Drummond, J., Zhang, X., Ding, X., et al. (2012). Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Sci. Transl. Med. 4, 164ra161.10.1126/scitranslmed.3004485Search in Google Scholar PubMed

Sirajuddin, M., Farkasovsky, M., Hauer, F., Kühlmann, D., Macara, I.G., Weyand, M., Stark, H., and Wittinghofer, A. (2007). Structural insight into filament formation by mammalian septins. Nature 449, 311–315.10.1038/nature06052Search in Google Scholar PubMed

Smith, W.W., Pei, Z., Jiang, H., Dawson, V.L., Dawson, T.M., and Ross, C.A. (2006). Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231–1233.10.1038/nn1776Search in Google Scholar PubMed

Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., Lorentzen, E., Duddy, G., Wilson, S., et al. (2016). Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases. eLife 5. Doi: 10.7554/eLife.12813.10.7554/eLife.12813Search in Google Scholar PubMed PubMed Central

Sumita, K., Lo, Y.-H., Takeuchi, K., Senda, M., Kofuji, S., Ikeda, A., Terakawa, J., Sasaki, M., Yoshino, H., Majd, N., et al. (2017). The lipid kinase PI5P4Kβ is an intracellular GTP sensor for metabolism and tumorigenesis. Mol. Cell 61, 187–198.10.1016/j.molcel.2015.12.011Search in Google Scholar PubMed PubMed Central

Sundal, C., Fujioka, S., Uitti, R.J., and Wszolek, Z.K. (2012). Autosomal dominant Parkinson’s disease. Parkinsonism Relat. Disord. 18, S7–S10.10.1016/S1353-8020(11)70005-0Search in Google Scholar PubMed

Taymans, J.-M., Vancraenenbroeck, R., Ollikainen, P., Beilina, A., Lobbestael, E., De Maeyer, M., Baekelandt, V., and Cookson, M.R. (2011). LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS One 6, e23207.10.1371/journal.pone.0023207Search in Google Scholar PubMed PubMed Central

Terheyden, S., Ho, F.Y., Gilsbach, B.K., Wittinghofer, A., and Kortholt, A. (2015). Revisiting the Roco G-protein cycle. Biochem. J. 465, 139–147.10.1042/BJ20141095Search in Google Scholar PubMed

Traut, T.W. (1994). Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1–22.10.1007/BF00928361Search in Google Scholar PubMed

van Egmond, W.N., Kortholt, A., Plak, K., Bosgraaf, L., Bosgraaf, S., Keizer-Gunnink, I., and van Haastert, P.J.M. (2008). Intramolecular activation mechanism of the Dictyostelium LRRK2 homolog Roco protein GbpC. J. Biol. Chem. 283, 30412–30420.10.1074/jbc.M804265200Search in Google Scholar PubMed PubMed Central

Vetter, I.R. and Wittinghofer, A. (2001). The guanine nucleotide-binding switch in three dimensions. Science 294, 1299–1304.10.1126/science.1062023Search in Google Scholar PubMed

West, A.B., Moore, D.J., Biskup, S., Bugayenko, A., Smith, W.W., Ross, C.A., Dawson, V.L., and Dawson, T.M. (2005). Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102, 16842–16847.10.1073/pnas.0507360102Search in Google Scholar PubMed PubMed Central

West, A.B., Moore, D.J., Choi, C., Andrabi, S.A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V.L., et al. (2007). Parkinson’s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223–232.10.1093/hmg/ddl471Search in Google Scholar PubMed

Wittinghofer, A. and Vetter, I.R. (2011). Structure-function relationships of the G domain, a canonical switch motif. Annu. Rev. Biochem. 80, 943–971.10.1146/annurev-biochem-062708-134043Search in Google Scholar PubMed

Xiong, Y., Yuan, C., Chen, R., Dawson, T.M., and Dawson, V.L. (2012). ArfGAP1 is a GTPase activating protein for LRRK2: reciprocal regulation of ArfGAP1 by LRRK2. J. Neurosci. 32, 3877–3886.10.1523/JNEUROSCI.4566-11.2012Search in Google Scholar PubMed PubMed Central

Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B., et al. (2004). Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44, 601–607.10.1016/j.neuron.2004.11.005Search in Google Scholar PubMed